NSCLC

You have access
Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of ⁸⁹Zr-Labeled Anti-PD-L1 Antibody Formats
Alizée Bouleau, Hervé Nozach, Steven Dubois, Dimitri Kereselidze, Céline Chevaleyre, Cheng-I Wang, Michael J. Evans, Vincent Lebon, Bernard Maillère and Charles Truillet

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1259-1265; DOI: https://doi.org/10.2967/jnumed.121.262967
You have access
Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen

Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
You have access
Comparison Between ¹⁸F-FDG PET–Based and CT-Based Criteria in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
Giovanni Rossi, Matteo Bauckneht, Carlo Genova, Erika Rijavec, Federica Biello, Simone Mennella, Maria Giovanna Dal Bello, Giuseppe Cittadini, Paolo Bruzzi, Roberta Piva, Valentina Ceriani, Gianmario Sambuceti, Egesta Lopci, Silvia Morbelli and Francesco Grossi

Journal of Nuclear Medicine July 1, 2020, 61 (7) 990-998; DOI: https://doi.org/10.2967/jnumed.119.233056
You have access
What ¹⁸F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball and Michael P. Mac Manus

Journal of Nuclear Medicine March 1, 2019, 60 (3) 328-334; DOI: https://doi.org/10.2967/jnumed.118.214148
You have access
Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non–Small Cell Lung Cancer
Zhaoguo Han, Yadi Xiao, Kai Wang, Ji Yan, Zunyu Xiao, Fang Fang, Zhongnan Jin, Yang Liu, Xilin Sun and Baozhong Shen

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1686-1691; DOI: https://doi.org/10.2967/jnumed.117.206730
You have access
Parametric Method Performance for Dynamic 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Carcinoma Patients Before and During Therapy
Gerbrand Maria Kramer, Virginie Frings, Dennis Heijtel, E.F. Smit, Otto S. Hoekstra and Ronald Boellaard; on behalf of the QuIC-ConCePT Consortium

Journal of Nuclear Medicine June 1, 2017, 58 (6) 920-925; DOI: https://doi.org/10.2967/jnumed.116.178418
You have access
Repeatability of Quantitative Whole-Body ¹⁸F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients
Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, Otto S. Hoekstra, Egbert F. Smit, Adrianus Johannes de Langen and Ronald Boellaard

Journal of Nuclear Medicine September 1, 2016, 57 (9) 1343-1349; DOI: https://doi.org/10.2967/jnumed.115.170225
You have access
¹⁸F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response
Irene A. Burger, Ruben Casanova, Seraina Steiger, Lars Husmann, Paul Stolzmann, Martin W. Huellner, Alessandra Curioni, Sven Hillinger, C. Ross Schmidtlein and Alex Soltermann

Journal of Nuclear Medicine June 1, 2016, 57 (6) 849-854; DOI: https://doi.org/10.2967/jnumed.115.167684
You have access
Evaluation of the Therapeutic and Diagnostic Effects of PEGylated Liposome–Embedded ¹⁸⁸Re on Human Non–Small Cell Lung Cancer Using an Orthotopic Small-Animal Model
Liang-Ting Lin, Chih-Hsien Chang, Hsiang-Lin Yu, Ren-Shyan Liu, Hsin-Ell Wang, Shu-Jun Chiu, Fu-Du Chen, Te-Wei Lee and Yi-Jang Lee

Journal of Nuclear Medicine November 1, 2014, 55 (11) 1864-1870; DOI: https://doi.org/10.2967/jnumed.114.140418
You have access
Assessment of Simplified Methods to Measure ¹⁸F-FLT Uptake Changes in EGFR-Mutated Non–Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment
Virginie Frings, Maqsood Yaqub, Lieke L. Hoyng, Sandeep S.V. Golla, Albert D. Windhorst, Robert C. Schuit, Adriaan A. Lammertsma, Otto S. Hoekstra, Egbert F. Smit, Ronald Boellaard and for the QuIC-ConCePT Consortium

Journal of Nuclear Medicine September 1, 2014, 55 (9) 1417-1423; DOI: https://doi.org/10.2967/jnumed.114.140913

Main menu

User menu

Search

NSCLC

Pages